Add nostrils and vaginas to the readily expanding list of human tissues doctors can now grow in laboratories and successfully implant in patients.
Two long-term studies just published in the influential medical journal The Lancet outline the success doctors have achieved in transplanting both body parts. In the first study, doctors at Wake Forest University harvested cells from the genitals of four teenage girls born with a syndrome that results in underdeveloped sexual organs, coaxed those cells into a regenerative state, grew them on a scaffold, and then transplanted the resulting tissue.
After eight years of follow up, “the organs continue to function as if they were native tissue and all recipients are sexually active, report no pain, and are satisfied with their desire/arousal, lubrication, and orgasm.”
In the second study, five people had their nostrils reconstructed with their own cartilage. That tissue was harvested from their own noses, and coaxed into expanding in volume by a factor of 40. It was then implanted. The research concludes that “the clinical reconstruction of the nasal [lobe] after resection of a non-melanoma skin cancer is safe and feasible.”
While these findings are certainly eyebrow-raising — and lend hope to those suffering with disfiguration — the more important aspect of their publication can be found in an op-ed published alongside the research.
Drs. Martin A. Birchall, and Alexander M. Seifalian write that these findings can be just as frustrating as they are promising. This research is considered disruptive medicine, and disruptions can take a very, very long time to make their way into mainstream medicine. And the high cost of developing such technology often poses roadblocks. Birchall and Seifalian write:
MRI scanners continue to improve generationally. These changes, which improve the patient’s experience and accuracy of diagnosis, are sustaining innovations: they improve an existing system that is understood by patients and that supports specialised industry, doctors, and health-care systems. By contrast, tissue engineering, and the various shades of regenerative and cellular therapies it partners, is a disruptive technology. …
Early automobile technology, although highly innovative, was the preserve of those who could afford it for many years. It was only when Henry Ford’s mass production brought automobiles to everyone’s street, in numbers yet at affordable cost, that the industry of the horse-drawn carriage passed away. These two Lancet studies show that those who practise conventional tissue reconstruction and organ transplantation, and the health-care and commercial industries which support them, should finally be taking the quirky minnows of tissue engineering quite seriously. Disruptive innovation might be nigh.
As I wrote in November, it will be some time before lab-grown organs are commonly available. Clinical trials for new procedures take decades. And “private industry is going to have to raise millions and millions of dollars not around the science, but around the practicality,” William Wagner, director of regenerative medicine at the University of Pittsburgh, told me then.
Roadblocks involving time and money are not exclusive to regenerative medicine. Take antibiotic research. Approvals of new antibiotics are currently at their lowest rate, at a time when threat of drug-resistant strains haven’t been higher. Or even sunscreen. Ingredients that European companies have been using for years, which work better than the ones currently available in the United States, are stuck in regulatory limbo.
That’s why Birchall and Seifalian provide a good reminder: Let’s turn some of these gee-whiz studies into reality.
What We're Following See More »
Twenty-one states, the District of Columbia and several public interest groups filed the first major lawsuits Tuesday to block the repeal of the Federal Communications Commission’s net neutrality rules. The FCC's rules had prohibited Internet providers from slowing down or blocking websites. New York Attorney General Eric Schneiderman, who is leading the states' suit, said that the FCC’s repeal was “arbitrary” and “capricious” and violates federal law. The suit comes just a day after Democrats in the Senate said they were inching closer to acquiring the votes needed to pass legislation overturning the FCC's rule change. It has garnered the support of all 49 Democratic senators as well as one Republican, Sen. Susan Collins (R-ME).
"A former C.I.A. officer suspected of helping China identify the agency’s informants in that country has been arrested, the Justice Department said on Tuesday. Many of the informants were killed in a systematic dismantling of the C.I.A.’s spy network in China starting in 2010 that was one of the American government’s worst intelligence failures in recent years, several former intelligence officials have said. The arrest of the former agent, Jerry Chun Shing Lee, 53, capped an intense F.B.I. investigation that began around 2012 after the C.I.A. began losing its informants in China."
"Three-quarters of the members of a federally chartered board advising the National Park Service abruptly quit Monday night out of frustration that Interior Secretary Ryan Zinke had refused to meet with them or convene a single meeting last year. The resignation of nine out of 12 National Park System Advisory Board members leaves the federal government without a functioning body to designate national historic or natural landmarks. It also underscores the extent to which federal advisory bodies have become marginalized under the Trump administration."
"House GOP leaders on Tuesday night pitched a new strategy to avert a looming government shutdown that includes children's health funding and the delay of ObamaCare taxes. Lawmakers need to pass a short-term stopgap bill by midnight Friday, when money for the federal government runs out. The latest GOP plan would keep the government’s lights on through Feb. 16, and be coupled with a six-year extension of funding for the popular Children's Health Insurance Program (CHIP). The continuing resolution or CR would also delay ObamaCare's medical device and Cadillac taxes for two years, and the health insurance tax for one year starting in 2019."
"A key Senate negotiator and White House official on Tuesday expressed little hope for an immigration deal this week but nonetheless predicted that Congress can avoid a government shutdown." Marc Short, the White House Capitol Hill liaison, said he's optimistic about a deal on DACA overall, but not this week. Senate Majority Whip John Cornyn also said he doubts an agreement can be made before week's end.